FERRARO, EMANUELA
FERRARO, EMANUELA
Universita' degli Studi di MILANO
Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions
2026 J. Iranzo, E. Giordano, R.M. Marsicano, D. Trapani, A. Marra, C. Belli, P. Zagami, P.P.M. Berton Giachetti, E. Ferraro, I. Minchella, E. Crimini, G. Curigliano
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer
2026 A. Safonov, M. Lee, D.N. Brown, L. Boscolo Bielo, M. Mehine, C. Bandlamudi, B. O'Leary, H. Shao, L. Vicente, D. Muldoon, A. Zhu, S. Ros, A. Marra, P. Selenica, I. Bieche, B. Wubbenhorst, E. Ferraro, L. Courtois, R. El Botty, M. Ahmed, E. Moiso, J.A.-. An, M.T.A. Donoghue, M. Will, F. Pareja, E. Nizialek, N. Lukashchuk, E. Sofianopoulou, Y. Liu, X. Huang, C. Chappey, A.D. Staniszewska, D. Ross, D. Mandelker, M. Ladanyi, N. Schultz, M.F. Berger, M. Scaltriti, J.S. Reis-Filho, B.T. Li, K. Offit, L. Norton, R. Shen, K.N. Maxwell, F. Couch, S.M. Domchek, E. Marangoni, S. Shah, M.R. Albertella, V. Serra, B. Weigelt, D.B. Solit, K.L. Nathanson, M.E. Robson, N.C. Turner, S. Chandarlapaty, P. Razavi
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials
2024 E. Nicolò, S. Gandini, F. Giugliano, J. Uliano, O. D'Ecclesiis, S. Morganti, E. Ferraro, D. Trapani, P. Tarantino, P. Zagami, L. Boldrini, I. Caramella, A. Carnevale Schianca, M. Cristofanilli, M.A. Locatelli, A. Esposito, C. Belli, I. Minchella, C. Criscitiello, A. Marra, G. Curigliano
Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast Cancer
2023 A. Marra, D. Trapani, E. Ferraro, G. Curigliano
Innovative Therapeutic Approaches for Patients with HER2-Positive Breast Cancer
2023 B. Taurelli Salimbeni, E. Ferraro, L. Boscolo Bielo, G. Curigliano
Postneoadjuvant treatment for triple-negative breast cancer
2022 D. Trapani, E. Ferraro, F. Giugliano, L. Boscolo Bielo, G. Curigliano, H.J. Burstein
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls
2022 S. Morganti, M. Ivanova, E. Ferraro, L. Ascione, G. Vivanet, G. Bonizzi, G. Curigliano, N. Fusco, C. Criscitiello
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review
2021 D. Trapani, F. Giugliano, J. Uliano, V.A.A. Zia, A. Marra, G. Viale, E. Ferraro, A. Esposito, C. Criscitiello, P. D'Amico, G. Curigliano
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET)
2021 C. Vernieri, F. Nichetti, L. Lalli, L. Moscetti, C.A. Giorgi, G. Griguolo, A. Marra, G. Randon, C.G. Rea, F. Ligorio, S. Scagnoli, C. De Angelis, C. Molinelli, A. Fabbri, E. Ferraro, D. Trapani, A. Milani, E. Agostinetto, O. Bernocchi, G. Catania, A. Vantaggiato, M. Palleschi, A. Moretti, D. Basile, M. Cinausero, A. Ajazi, L. Castagnoli, S. Lo Vullo, L. Gerratana, F. Puglisi, N. La Verde, G. Arpino, A. Rocca, M. Ciccarese, R. Pedersini, A. Fabi, D. Generali, A. Losurdo, F. Montemurro, G. Curigliano, L. Del Mastro, A. Michelotti, E. Cortesi, V. Guarneri, G. Pruneri, L. Mariani, F. de Braud
HER2-Low Breast Cancer: Pathological and Clinical Landscape
2020 P. Tarantino, E. Hamilton, S.M. Tolaney, J. Cortes, S. Morganti, E. Ferraro, A. Marra, G. Viale, D. Trapani, F. Cardoso, F. Penault-Llorca, G. Viale, F. Andre, G. Curigliano
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
2019 S. Morganti, P. Tarantino, E. Ferraro, P. D'Amico, G. Viale, D. Trapani, B.A. Duso, G. Curigliano
Evaluating triptorelin as a treatment option for breast cancer
2019 E. Ferraro, D. Trapani, E. Marrucci, G. Curigliano
The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
2019 L. Mazzarella, B.A. Duso, D. Trapani, C. Belli, P. D'Amico, E. Ferraro, G. Viale, G. Curigliano
What therapies are on the horizon for HER2 positive breast cancer?
2019 G. Viale, S. Morganti, E. Ferraro, P. Zagami, A. Marra, G. Curigliano